Regenxbio Inc (NASDAQ:RGNX)

17.10
Delayed Data
As of Sep 22
 -0.52 / -2.95%
Today’s Change
16.93
Today|||52-Week Range
27.20
-24.60%
Year-to-Date
No recent news for Regenxbio Inc.

Today’s Trading

Previous close17.62
Today’s open17.31
Day’s range17.10 - 17.51
Volume13,542
Average volume (3 months)366,529
Market cap$752.6M
Data as of 3:59pm ET, 09/22/2023

Growth & Valuation

Earnings growth (last year)-315.65%
Earnings growth (this year)+31.55%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)-76.03%
P/E ratioNM
Price/Sales8.68
Price/Book1.44

Competitors

 Today’s
change
Today’s
% change
IBRXImmunitybio Inc+0.01+0.61%
SAVACassava Sciences Inc-0.15-0.85%
----
ADMAADMA Biologics Inc-0.04-1.12%
Data as of 3:59pm ET, 09/22/2023

Financials

Next reporting dateNovember 8, 2023
EPS forecast (this quarter)-$1.10
Annual revenue (last year)$112.7M
Annual profit (last year)-$280.3M
Net profit margin-248.68%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Rockville, Maryland

Forecasts